Supplementation with antioxidants fails to increase the total antioxidant capacity of several cell lines in culture

Biomedicine and Pharmacotherapy

Volumn 62, Issue 3, 2008, Pages 179-188

  Koren, Erez ^a   Zverev, Igor ^a   Ginsburg, Isaac ^a   Kohen, Ron ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Antioxidants; Intracellular antioxidant concentration; Low molecular weight antioxidants; Regulation; Supplementation; Total antioxidant capacity

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID 2 PHOSPHATE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ASSAY; CELL CULTURE; CELL LEVEL; CELL LINE; CELL STRAIN CACO 2; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SUPPLEMENTATION; TECHNIQUE;

ACETYLCYSTEINE; ANTIMETABOLITES; ANTIOXIDANTS; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; FERRIC COMPOUNDS; FREE RADICAL SCAVENGERS; GLUTATHIONE; HUMANS; KERATINOCYTES; PROTEINS; REACTIVE OXYGEN SPECIES; URIC ACID;

EID: 40749139489     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.12.012     Document Type: Article

References (57)

1. Crimi E., Sica V., Williams-Ignarro S., Zhang H., Slutsky A.S., Ignarro L.J., et al. The role of oxidative stress in adult critical care. Free Radic Biol Med 40 (2006) 398-406
2. Rodrigo R., and Bosco C. Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review. Comp Biochem Physiol C Toxicol Pharmacol 142 (2006) 317-327
3. Hensley K., Robinson K.A., Gabbita S.P., Salsman S., and Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 28 (2000) 1456-1462
4. Kohen R., and Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30 (2002) 620-650
5. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39 (2005) 359-407
6. Esterbauer H., Gebicki J., Puhl H., and Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13 (1992) 341-390
7. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141 (1998) 1-15
8. Agarwal A., Gupta S., and Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol 18 (2006) 325-332
9. Beckman K.B., and Ames B.N. The free radical theory of aging matures. Physiol Rev 78 (1998) 547-581
10. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 25 (1996) 57-74
11. Heinecke J.W. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 91 (2003) 12A-16A
12. Colquhoun D.M. Nutraceuticals: vitamins and other nutrients in coronary heart disease. Curr Opin Lipidol 12 (2001) 639-646
13. Fairfield K.M., and Fletcher R.H. Vitamins for chronic disease prevention in adults: scientific review. JAMA 287 (2002) 3116-3126
14. Hooper L., Ness A.R., and Smith G.D. Antioxidant strategy for cardiovascular diseases. Lancet 357 (2001) 1705-1706
15. McCall M.R., and Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans?. Free Radic Biol Med 26 (1999) 1034-1053
16. Kirsh V.A., Hayes R.B., Mayne S.T., Chatterjee N., Subar A.F., Dixon L.B., et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 98 (2006) 245-254
17. Poston L., Briley A.L., Seed P.T., Kelly F.J., and Shennan A.H. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367 (2006) 1145-1154
18. Ueda S., and Yasunari K. What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease. Curr Pharm Biotechnol 7 (2006) 69-72
19. Stocker R., and Keaney Jr. J.F. New insights on oxidative stress in the artery wall. J Thromb Haemost 3 (2005) 1825-1834
20. Bjelakovic G., Nikolova D., Simonetti R.G., and Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364 (2004) 1219-1228
21. Eidelman R.S., Hollar D., Hebert P.R., Lamas G.A., and Hennekens C.H. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 164 (2004) 1552-1556
22. Kraemer K., Koch W., and Hoppe P.P. Is all-RAC-alpha-tocopherol different from RRR-alpha-tocopherol regarding cardiovascular efficacy? A meta-analysis of clinical trials. Ann N Y Acad Sci 1031 (2004) 435-438
23. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., and Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361 (2003) 2017-2023
24. Miller III E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142 (2005) 37-46
25. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106 (1988) 761-771
26. Griffith O.W., and Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 254 (1979) 7558-7560
27. Nomura H., Ishiguro T., and Morimoto S. Studies on l-ascorbic acid derivatives. 3. Bis(l-ascorbic acid-3,3′)phosphate and l-ascorbic acid 2-phosphate. Chem Pharm Bull (Tokyo) 17 (1969) 387-393
28. Morisaki K., and Ozaki S. Synthesis of novel vitamin C phosphodiesters: stability and antioxidant activity. Carbohydr Res 286 (1996) 123-138
29. Hitomi K., Torii Y., and Tsukagoshi N. Increase in the activity of alkaline phosphatase by l-ascorbic acid 2-phosphate in a human osteoblast cell line, HuO-3N1. J Nutr Sci Vitaminol (Tokyo) 38 (1992) 535-544
30. Omaye S.T., Turnbull J.D., and Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 62 (1979) 3-11
31. Kohen R., Vellaichamy E., Hrbac J., Gati I., and Tirosh O. Quantification of the overall reactive oxygen species scavenging capacity of biological fluids and tissues. Free Radic Biol Med 28 (2000) 871-879
32. Wayner D.D., Burton G.W., Ingold K.U., and Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett 187 (1985) 33-37
33. Lissi E., Salim-Hanna M., Pascual C., and del Castillo M.D. Evaluation of total antioxidant potential (trap) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 18 (1995) 153-158
34. Cao G., Verdon C.P., Wu A.H., Wang H., and Prior R.L. Automated assay of oxygen radical absorbance capacity with the COBAS FARA II. Clin Chem 41 (1995) 1738-1744
35. Prior R.L., Hoang H., Gu L., Wu X., Bacchiocca M., Howard L., et al. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and food samples. J Agric Food Chem 51 (2003) 3273-3279
36. Benzie I.F., and Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239 (1996) 70-76
37. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30 (2001) 1191-1212
38. Reed D.J., Babson J.R., Beatty P.W., Brodie A.E., Ellis W.W., and Potter D.W. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem 106 (1980) 55-62
39. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
40. Savini I., D'Angelo I., Ranalli M., Melino G., and Avigliano L. Ascorbic acid maintenance in HaCaT cells prevents radical formation and apoptosis by UV-B. Free Radic Biol Med 26 (1999) 1172-1180
41. Motchnik P.A., Frei B., and Ames B.N. Measurement of antioxidants in human blood plasma. Methods Enzymol 234 (1994) 269-279
42. Dubnov G., Kohen R., and Berry E.M. Diet restriction in mice causes differential tissue responses in total reducing power and antioxidant compounds. Eur J Nutr 39 (2000) 18-30
43. Bakan V., Demirtas I., and Dulger H. The antioxidant paradox or antioxidant damage. Pediatr Surg Int 20 (2004) 903
44. Halliwell B. The antioxidant paradox. Lancet 355 (2000) 1179-1180
45. Etminan M., Gill S.S., and Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol 4 (2005) 362-365
46. Kris-Etherton P.M., Lichtenstein A.H., Howard B.V., Steinberg D., and Witztum J.L. Antioxidant vitamin supplements and cardiovascular disease. Circulation 110 (2004) 637-641
47. Pham D.Q., and Plakogiannis R. Vitamin E supplementation in cardiovascular disease and cancer prevention: part 1. Ann Pharmacother 39 (2005) 1870-1878
48. Rumbold A., and Crowther C.A. Vitamin E supplementation in pregnancy. Cochrane Database Syst Rev (2005) CD004069
49. Rumbold A.R., Crowther C.A., Haslam R.R., Dekker G.A., and Robinson J.S. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354 (2006) 1796-1806
50. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 (2007) 842-857
51. Serafini M., and Del Rio D. Understanding the association between dietary antioxidants, redox status and disease: Is the total antioxidant capacity the right tool?. Redox Rep 9 (2004) 145-152
52. Higdon J.V., and Frei B. Is there a gender difference in the effect of antioxidants on cancer risk?. Br J Nutr 94 (2005) 139-140
53. Lotito S.B., and Frei B. The increase in human plasma antioxidant capacity after apple consumption is due to the metabolic effect of fructose on urate, not apple-derived antioxidant flavonoids. Free Radic Biol Med 37 (2004) 251-258
54. Berry E.M., and Kohen R. Is the biological antioxidant system integrated and regulated?. Med Hypotheses 53 (1999) 397-401
55. Sheu S.S., Nauduri D., and Anders M.W. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta 1762 (2006) 256-265
56. Manach C., Williamson G., Morand C., Scalbert A., and Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81 (2005) 230S-242S
57. Sies H., Stahl W., and Sevanian A. Nutritional, dietary and postprandial oxidative stress. J Nutr 135 (2005) 969-972